Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Sales (2018 - 2025)

TransMedics (TMDX) has 8 years of Return on Sales data on record, last reported at 0.42% in Q4 2025.

  • For Q4 2025, Return on Sales fell 19.0% year-over-year to 0.42%; the TTM value through Dec 2025 reached 0.02%, up 2.0%, while the annual FY2025 figure was 0.31%, 31.0% up from the prior year.
  • Return on Sales reached 0.42% in Q4 2025 per TMDX's latest filing, down from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.95% in Q4 2022 and bottomed at 2.39% in Q3 2021.
  • Average Return on Sales over 5 years is 0.32%, with a median of 0.15% recorded in 2024.
  • Peak YoY movement for Return on Sales: crashed -168bps in 2021, then soared 226bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 1.31% in 2021, then surged by 172bps to 0.95% in 2022, then tumbled by -59bps to 0.38% in 2023, then plummeted by -161bps to 0.23% in 2024, then tumbled by -81bps to 0.42% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.42% in Q4 2025, 0.14% in Q3 2025, and 0.21% in Q2 2025.